{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:31:26Z","timestamp":1793845886494,"version":"4.6.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.biopha.2021.111567","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T14:15:14Z","timestamp":1618323314000},"page":"111567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Antihypertensive potential of selected pyrimidine derivatives: Explanation of underlying mechanistic pathways"],"prefix":"10.1016","volume":"139","author":[{"given":"Nadeem","family":"Irshad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif-ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Alamgeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah-Ud-Din","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2021.111567_bib1","unstructured":"WHO, A Global Brief on Hypertension, Silent Killer, Global Public Health Crisis, WHO, Geneva, Switzerland, 2013."},{"key":"10.1016\/j.biopha.2021.111567_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.gheart.2012.12.004","article-title":"Hypertension and cardiovascular disease: contributions of the Framingham heart study","volume":"8","author":"Franklin","year":"2013","journal-title":"Glob. Heart"},{"key":"10.1016\/j.biopha.2021.111567_bib3","volume":"176","author":"Alwan","year":"2011"},{"key":"10.1016\/j.biopha.2021.111567_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.biopha.2021.111567_bib5","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.freeradbiomed.2011.05.004","article-title":"Reactive oxygen species in cardiovascular disease","volume":"51","author":"Sugamura","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2021.111567_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pharmthera.2011.11.004","article-title":"The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion","volume":"133","author":"Raedschelder","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2021.111567_bib7","first-page":"129","article-title":"Design, synthesis, and antihypertensive activity of curcumin-inspired compounds via ace inhibition and vasodilation, along with a bioavailability study for possible benefit in cardiovascular diseases","volume":"10","author":"Zhuang","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.biopha.2021.111567_bib8","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1021\/jm201446h","article-title":"Pyrazolo [4, 3-c] [1,2] benzothiazines 5, 5-Dioxide: a promising new class of Staphylococcus aureus NorA efflux pump inhibitors","volume":"55","author":"Sabatini","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111567_bib9","doi-asserted-by":"crossref","first-page":"9958","DOI":"10.1021\/jm301164y","article-title":"Synthesis and biological evaluation of 5\u2013benzylidenepyrimidine 2, 4, 6(1H, 3H, 5H) -trione derivatives for the treatment of obesity related nonalcoholic fatty liver disease","volume":"55","author":"Ma","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111567_bib10","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1021\/jm4005048","article-title":"Structure\u2013activity relationship of N, N-disubstituted pyrimidinetriones as CaV1.3 calcium channel-selective antagonists for Parkinson\u2019s disease","volume":"56","author":"Kang","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111567_bib11","first-page":"574","article-title":"An overview of biological importance of pyrimidine","volume":"3","author":"Singh","year":"2014","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.111567_bib12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.molstruc.2015.06.037","article-title":"Synthesis and structure investigation of novel pyrimidine-2, 4, 6-trione derivatives of highly potential biological activity as anti-diabetic agent","volume":"1098","author":"Barakat","year":"2015","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.biopha.2021.111567_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.metabol.2011.12.012","article-title":"Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation","volume":"61","author":"Prahalathan","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2021.111567_bib14","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/ki.2008.300","article-title":"Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension","volume":"74","author":"Zhou","year":"2008","journal-title":"Kid. Int."},{"key":"10.1016\/j.biopha.2021.111567_bib15","first-page":"121","article-title":"Hypotensive effect of Gentiana floribunda is mediated through Ca antagonism pathway","volume":"12","author":"Khan","year":"2012","journal-title":"CAM"},{"key":"10.1016\/j.biopha.2021.111567_bib16","first-page":"6","article-title":"Pharmacodynamic evaluation of Terminalia bellerica for its antihypertensive effect","volume":"16","author":"Khan","year":"2008","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.biopha.2021.111567_bib17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/biom10060816","article-title":"Post-treatment of synthetic polyphenolic 1,3,4 oxadiazole compound A3 attenuated ischemic stroke-induced neuroinflammation and neurodegeneration","volume":"10","author":"Alvi","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2021.111567_bib18","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3389\/fneur.2019.01178","article-title":"Pathological comparisons of the hippocampal changes in the transient and permanent middle cerebral artery occlusion rat models","volume":"10","author":"Shah","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.biopha.2021.111567_bib19","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ddr.21495","article-title":"The protective effect of kaempferol on heart via the regulation of Nrf2, NF-kB and PI3K\/Akt\/GSK-3b signaling pathways in isoproterenol-induced heart failure in diabetic rats","volume":"80","author":"Zhang","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.biopha.2021.111567_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00395-007-0658-z","article-title":"Survival pathways in hypertrophy and heart failure: the gp130-stat3 axis","volume":"102","author":"Fischer","year":"2007","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.biopha.2021.111567_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/01.HYP.2.3.266","article-title":"Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat","volume":"2","author":"Katholi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2021.111567_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1067\/mhj.2003.22","article-title":"Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry","volume":"145","author":"Bauriedel","year":"2003","journal-title":"Am. Heart J."},{"key":"10.1016\/j.biopha.2021.111567_bib23","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.2147\/DDDT.S198865","article-title":"Synthesis and antihepatotoxic activity of dihydropyrimidinone derivatives linked with 1,4-benzodioxane","volume":"13","author":"Bhat","year":"2019","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.biopha.2021.111567_bib24","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1021\/jm801178c","article-title":"Discovery and structure-activity relationships of trisubstituted pyrimidines\/pyridines as novel calcium-sensing receptor antagonists","volume":"52","author":"Yang","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111567_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms19030660","article-title":"Chronic blockade of brain endothelin receptor type-A (ETA) reduces blood pressure and prevents catecholaminergic overactivity in the right olfactory bulb of DOCA-salt hypertensive rats.","volume":"19","author":"Cassinotti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2021.111567_bib26","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/hh1901.097126","article-title":"Differential expression of T-type and L-type voltage dependent Ca channels in renal resistance vessels","volume":"89","author":"Hansen","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2021.111567_bib27","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/01.HYP.34.4.673","article-title":"Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats","volume":"34","author":"Karam","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2021.111567_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2191-2858-2-34","article-title":"Free radical scavenging properties of pyrimidine derivatives","volume":"2","author":"Bano","year":"2012","journal-title":"Org. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2021.111567_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1440-1681.2006.04373.x","article-title":"Direct effects of quercetin on impaired reactivity of spontaneously hypertensive rat aorta: comparative study with ascorbic acid","volume":"33","author":"Ajay","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2021.111567_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00005344-200501000-00013","article-title":"Ginger lowers blood pressure through blockade of voltage-dependent calcium channels","volume":"45","author":"Ghayur","year":"2005","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111567_bib31","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.amjhyper.2004.02.004","article-title":"Reactive oxygen species in hypertension","volume":"17","author":"Lassegue","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.biopha.2021.111567_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/157340310793566109","article-title":"The DOCA-salt hypertensive rat as a model of cardiovascular oxidative and inflammatory stress","volume":"6","author":"Iyer","year":"2010","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.biopha.2021.111567_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.vph.2006.02.004","article-title":"Mechanisms of agonist-induced constriction in isolated human mesenteric arteries","volume":"44","author":"Hall","year":"2006","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111567_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2005.01.021","article-title":"Depletion of Ca++ from intracellular stores of the rat portal vein stimulates a tonic contraction","volume":"510","author":"Burt","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111567_bib35","first-page":"417","article-title":"Antihypertensive properties of the novel calcium antagonist (1S, 2S)-2-[2-[[3-(2-benzimidazol) propyl] methylamino] ethyl]-6-fluoro-1, 2, 3, 4-tetrahydro-1-isopropyl-2-naph-thyl methoxyacetate dihydrochloride in rat models of hypertension","volume":"40","author":"Hefti","year":"1990","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.biopha.2021.111567_bib36","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/j.bmc.2017.02.015","article-title":"Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their ef\ufb01cacy as analgesics in mouse models of in\ufb02ammatory pain","volume":"25","author":"Teleb","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2021.111567_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/10641960902993111","article-title":"Evaluation of renal oxidative stress in the development of DOCA-salt induced hypertension and its renal damage","volume":"32","author":"Seifi","year":"2010","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.biopha.2021.111567_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3835(02)00203-3","article-title":"Modulation of carcinogenic response and antioxidant enzymes of rats administered with1, 2- dimethyl hydrazine by Picroliv","volume":"191","author":"Rajeshkumar","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2021.111567_bib39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/jfca.2001.1030","article-title":"Hydroxyl free radical-mediated oxidative degradation of quercetin and morin: a preliminary investigation","volume":"15","author":"Makris","year":"2002","journal-title":"J. Food Compos. Anal."},{"key":"10.1016\/j.biopha.2021.111567_bib40","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0895-7061(04)00811-8","article-title":"Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction with the renin-angiotensin system","volume":"17","author":"Iglarz","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.biopha.2021.111567_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2897867","article-title":"Antihypertensive activity of Leersia hexandra Sw. (Poaceae) aqueous extract on ethanol-induced hypertension in wistar rat","volume":"2897867","author":"Bilanda","year":"2019","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2021.111567_bib42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.taap.2005.10.012","article-title":"Nifedipine represses ion channels, transporters and Ca-binding proteins in heart of spontaneously hypertensive rats","volume":"213","author":"Zwaldo","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.biopha.2021.111567_bib43","series-title":"Lippincott\u2019s Illustrated Reviews: Pharmacology","first-page":"261","author":"Howland","year":"2006"},{"key":"10.1016\/j.biopha.2021.111567_bib44","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10593-008-0076-7","article-title":"4-hydroxy-2-quinolones 144. Alkyl-arylalkyl- and arylamides of 2-hydroxy-4-oxo-4H-pyrido [1,2-a] pyrimidine -3-carboxylic acid and their diuretic properties","volume":"44","author":"Ukrainets","year":"2008","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.biopha.2021.111567_bib45","first-page":"793","article-title":"Biological and medicinal significance of pyrimidines","volume":"90","author":"Jain","year":"2006","journal-title":"Curr. Sci."},{"key":"10.1016\/j.biopha.2021.111567_bib46","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1080\/14786410903335190","article-title":"Effect of myricetin on deoxycorticosterone acetate (DOCA)-salt hypertensive rats","volume":"25","author":"Borde","year":"2011","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2021.111567_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008522","article-title":"ADP platelet hyper reactivity predicts cardiovascular disease in the FHS (Framingham Heart Study)","volume":"7","author":"Puurunen","year":"2018","journal-title":"JAHA"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221003528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:20:37Z","timestamp":1760098837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221003528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":47,"alternative-id":["S0753332221003528"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111567","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antihypertensive potential of selected pyrimidine derivatives: Explanation of underlying mechanistic pathways","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.111567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"111567"}}